Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists

Overview of attention for article published in Vascular Health and Risk Management, October 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 47 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 17 publications that cite this research output.

17

The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.

Uncontrolled and resistant arterial hypertension: prevalence, methods of modification of therapy

Article in Systemic Hypertension (January 2023)

Analysis of lifestyle modifications and antihypertensive therapy in patients with arterial hypertension and chronic kidney disease (data from the national registry)

Article in Systemic Hypertension (December 2022)

Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT)

Article in Vascular Health and Risk Management (December 2022)